Chiniara Ellen
SEC insider (Form 3/4/5 filer). CIK 0001398764. Director at Compass Therapeutics, Inc. (CMPX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in BOSTON, MA.
Companies Chiniara Ellen has filed insider reports for
- Compass Therapeutics, Inc. (CMPX): Director
- Kymera Therapeutics, Inc. (KYMR): Officer, Chief Legal Officer
Chiniara Ellen
CIK: 0001398764
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 2, 2026CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
90K shares- - Mar 3, 2025KYMR
Kymera Therapeutics, Inc.
AwardDirect27.5K shares- - Mar 3, 2025KYMR
Kymera Therapeutics, Inc.
SaleDirect1.8K shares at avg. $30.33$56K - Mar 3, 2025KYMR
Kymera Therapeutics, Inc.
SaleDirect408 shares at avg. $31.00$13K - Feb 11, 2025CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Jan 6, 2025KYMR
Kymera Therapeutics, Inc.
SaleDirect3.1K shares at avg. $41.75$131K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 |  CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Mar 3, 2025 |  KYMR Kymera Therapeutics, Inc. | Award | 27,500 | - | - | Direct |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | Sale | 1,833 | $30.33 | $55,590 | Direct |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | Sale | 408 | $31.00 | $12,650 | Direct |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Jan 6, 2025 | KYMR Kymera Therapeutics, Inc. | Sale | 3,129 | $41.75 | $130,645 | Direct |
1-6 of 6 transactions